These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18327563)

  • 1. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease.
    Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT
    J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16.
    Djoussé L; Knowlton B; Hayden MR; Almqvist EW; Brinkman RR; Ross CA; Margolis RL; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo Cabrero D; Jones R; Zanko A; Nance M; Abramson RK; Suchowersky O; Paulsen JS; Harrison MB; Yang Q; Cupples LA; Mysore J; Gusella JF; MacDonald ME; Myers RH
    Neurogenetics; 2004 Jun; 5(2):109-14. PubMed ID: 15029481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease.
    Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT
    Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
    Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
    BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner.
    Arning L; Saft C; Wieczorek S; Andrich J; Kraus PH; Epplen JT
    Hum Genet; 2007 Sep; 122(2):175-82. PubMed ID: 17569088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.
    Valcárcel-Ocete L; Alkorta-Aranburu G; Iriondo M; Fullaondo A; García-Barcina M; Fernández-García JM; Lezcano-García E; Losada-Domingo JM; Ruiz-Ojeda J; Álvarez de Arcaya A; Pérez-Ramos JM; Roos RA; Nielsen JE; Saft C; ; Zubiaga AM; Aguirre A
    PLoS One; 2015; 10(7):e0131573. PubMed ID: 26148071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
    Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
    J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease.
    Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L
    BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNR1 variation is associated with the age at onset in Huntington disease.
    Kloster E; Saft C; Epplen JT; Arning L
    Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study.
    Li JL; Hayden MR; Warby SC; Durr A; Morrison PJ; Nance M; Ross CA; Margolis RL; Rosenblatt A; Squitieri F; Frati L; Gómez-Tortosa E; García CA; Suchowersky O; Klimek ML; Trent RJ; McCusker E; Novelletto A; Frontali M; Paulsen JS; Jones R; Ashizawa T; Lazzarini A; Wheeler VC; Prakash R; Xu G; Djoussé L; Mysore JS; Gillis T; Hakky M; Cupples LA; Saint-Hilaire MH; Cha JH; Hersch SM; Penney JB; Harrison MB; Perlman SL; Zanko A; Abramson RK; Lechich AJ; Duckett A; Marder K; Conneally PM; Gusella JF; MacDonald ME; Myers RH
    BMC Med Genet; 2006 Aug; 7():71. PubMed ID: 16914060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
    Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
    J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset.
    Ramos EM; Latourelle JC; Lee JH; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME
    Hum Genet; 2012 Dec; 131(12):1833-40. PubMed ID: 22825315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modifier of Huntington's disease onset at the MLH1 locus.
    Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
    Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetics of Huntington's disease].
    Goto J; Masuda N; Watanabe M; Kanazawa I
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage disequilibrium between the expanded (CAG)n repeat and an allele of the adjacent (CCG)n repeat in Huntington's disease patients of Greek origin.
    Yapijakis C; Vassilopoulos D; Tzagournisakis M; Maris T; Fesdjian C; Papageorgiou C; Plaitakis A
    Eur J Hum Genet; 1995; 3(4):228-34. PubMed ID: 8528671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Soliveri P; Lange HW; Weirich-Schwaiger H; Wenning GK; Melegh B; Havasi V; Balikó L; Wieczorek S; Arning L; Zaremba J; Sulek A; Hoffman-Zacharska D; Basak AN; Ersoy N; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Neurogenetics; 2006 Mar; 7(1):27-30. PubMed ID: 16369839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA haplotype analysis of CAG repeat in Taiwanese Huntington's disease patients.
    Wang CK; Wu YR; Hwu WL; Chen CM; Ro LS; Chen ST; Gwinn-Hardy K; Yang CC; Wu RM; Chen TF; Wang HC; Chao MC; Chiu MJ; Lu CJ; Lee-Chen GJ
    Eur Neurol; 2004; 52(2):96-100. PubMed ID: 15273431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds.
    Gayán J; Brocklebank D; Andresen JM; Alkorta-Aranburu G; ; Zameel Cader M; Roberts SA; Cherny SS; Wexler NS; Cardon LR; Housman DE
    Genet Epidemiol; 2008 Jul; 32(5):445-53. PubMed ID: 18481795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.